November 2007 Volume 3, Issue 11
Volume 3, Issue 11 | November 2007
November 2007
In this Issue
Research & Development
Neglected no longer?
Tackling infectious disease where it livesFrom service to innovation
The next stage in Indian pharma evolutionDueling with diabetes
Vitae and Boehringer Ingelheim pair up to advance an inhibitor with promise to treat diabetes and other related disease statesFrom service to innovation
The next stage in Indian pharma evolution is on the wayBack to nature
Cystic Fibrosis Foundation enters deal with AMRIInformatics
Malaria “Survey”
U.S. Army research from 1946 plus 21st century informatics aid in research of resistant strains of malariaCustomized CRO services
Nextrials, Protrials team up to provide integrated clinical servicesFloating to the top?
CambridgeSoft seeks to float its stock on alternative market operated by the London Stock ExchangeFast track for Compendia
Company secures $2.4 million Phase I and II SBIR grantGlobal News
Blockbuster oncology deal
Synta could reap more than $1 billion from deal with GSK on STA-4783Genzyme seals Bioenvision deal
Company stands firm on offer of $345 million for New York-based biotechGenomics & Proteomics
Getting personal in Arizona
Piper Trust, Flinn Foundation fund personalized medicine initiativeAdding to the family tree
BioServe, DNAPrint Genomics add ancestry data to biological samplesContinued transformation
Gene Logic sells genomics assets to Ocimum Biosolutions for $10 millionAutomation & Instrumentation
Getting a foot in the door
Agilent-BioTrove co-marketing deal could open opportunities for closer tiesImaging is everything
Alpha Innotech to create new device for OEM agreement with R&C Biogenius
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
Supercharging cell line development and engineering with automated single cell sorting
Researchers can enhance efficiency, yield, and consistency in clonal cell line development with specialized tools.
